Sunday, November 02, 2014 11:36:27 PM
Follow this scenario with "firm" revenue numbers for LymPro in the $25M+ range for 2015 and several times that amount for 2016 and the share price firms up in the .50 range as additional O.D.D. applications for MANF are filed and additional development partnerships anticipated.
A reasonable share price would be .50 by the end of 2Q2015 although it could be much higher. Who thought the share price of JAZZ would explode like it did?
Considering the recent price action I don't see much if any downside buying at the current share price.
I don't know of another stock currently under a dime that has the potential that AMBS offers.
Interesting weeks ahead.
Twitter: @AmarantusBio .... 10,200 followers.
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM